The impact of Indigenous American-like ancestry on the risk of acute lymphoblastic leukemia in Hispanic/Latino children
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, with Hispanic/Latino children having a higher incidence of ALL than other racial/ethnic groups. Among the genetic variants previously implicated in ALL risk, a number of them were found to be enriched in Indigenous American (IA)-like ancestries and inherited by many Hispanic/Latino individuals. However, due to potential confounding from environmental factors, the association between IA-like ancestry and risk for ALL has remained unclear. In this study, we characterized the impact of IA-like ancestry on overall ALL risk and on the frequency and effect size of known risk alleles, while accounting for non-genetic correlates of ancestry. Contrary to previous findings, we found that global IA-like ancestry was not significantly associated with ALL risk after adjusting for socioeconomic indicators. However, locally at known ALL risk regions, we uncovered that increasing copies of the IA-like haplotype were positively and significantly associated with ALL risk (e.g., the IA-like haplotype had ∼1.33 times the odds of harboring the risk allele compared to non-IA-like haplotypes), but we found no evidence of interaction between genotype and ancestry in relation to ALL. Admixture mapping identified replicable association signals at chr7p12.2 and chr10q21.2, consistent with the benefit of leveraging genetic ancestry in identifying genetic risk loci. Our results suggest that increased risk of ALL in Hispanic/Latino children may be conferred by the higher frequency of risk alleles within IA-like ancestry and that local ancestry-based analyses are robust strategies to elucidate genetic etiology of disease.
Authors
- Michael E. Scheurer (ORCID: https://orcid.org/0000-0002-8379-6088)
- Karen R. Rabin (ORCID: https://orcid.org/0000-0002-4081-8195)
- Alice Y. Kang (ORCID: https://orcid.org/0009-0009-8455-3481)
- Nicholas Mancuso (ORCID: https://orcid.org/0000-0002-9352-5927)
- Wenjian Yang (ORCID: https://orcid.org/0000-0002-7305-5649)
- Libby M. Morimoto (ORCID: https://orcid.org/0000-0002-1509-739X)
- Joseph Leo Wiemels (ORCID: https://orcid.org/0000-0003-4838-9951)
- Daniel O. Stram (ORCID: https://orcid.org/0000-0001-7099-9022)
- Adam J. de Smith (ORCID: https://orcid.org/0000-0003-4880-7543)
- Charleston W. K. Chiang (ORCID: https://orcid.org/0000-0002-0668-7865)
- Jun J. Yang (ORCID: https://orcid.org/0000-0002-0770-9659)
- Catherine Metayer (ORCID: https://orcid.org/0000-0003-3467-4145)
- Tsz Fung Chan (ORCID: https://orcid.org/0000-0003-3438-4068)
- Philip J. Lupo (ORCID: https://orcid.org/0000-0003-0978-5863)
- Xiaomei Ma (ORCID: https://orcid.org/0000-0001-9472-8032)
- Jalen Langie (ORCID: https://orcid.org/0000-0002-9651-457X)
Institutions
- University of Southern California (US)
- St. Jude Children's Research Hospital (US)
- Yale University (US)
- Texas Children's Hospital (US)
- Berkeley Public Health Division (US)
- Children's Cancer Center (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- Human Genetics and Genomics Advances
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.xhgg.2025.100534
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00